129 related articles for article (PubMed ID: 19854251)
1. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.
Han YH; Park WH
Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
Park WH
Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
[TBL] [Abstract][Full Text] [Related]
3. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
You BR; Park WH
Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
[TBL] [Abstract][Full Text] [Related]
4. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
You BR; Park WH
J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
[TBL] [Abstract][Full Text] [Related]
5. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
Han YH; Moon HJ; You BR; Park WH
Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
[TBL] [Abstract][Full Text] [Related]
6. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion.
Han YH; Yang YM; Kim SZ; Park WH
Anticancer Res; 2010 Jun; 30(6):2107-12. PubMed ID: 20651358
[TBL] [Abstract][Full Text] [Related]
8. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH.
Han YH; Moon HJ; You BR; Park WH
Oncol Rep; 2009 Jul; 22(1):215-21. PubMed ID: 19513526
[TBL] [Abstract][Full Text] [Related]
9. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death.
Han YH; Park WH
Chem Biol Interact; 2010 Mar; 184(3):319-27. PubMed ID: 20100472
[TBL] [Abstract][Full Text] [Related]
10. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
11. The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132.
You BR; Park WH
Oncol Rep; 2011 Mar; 25(3):871-7. PubMed ID: 21186403
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736
[TBL] [Abstract][Full Text] [Related]
13. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
Park WH
Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
[TBL] [Abstract][Full Text] [Related]
14. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
Han YH; Park WH
Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
[TBL] [Abstract][Full Text] [Related]
15. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316
[TBL] [Abstract][Full Text] [Related]
16. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
Park WH; Kim SH
Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922
[TBL] [Abstract][Full Text] [Related]
17. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Park WH
Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
[TBL] [Abstract][Full Text] [Related]
18. MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion.
Han YH; Park WH
Toxicol In Vitro; 2010 Jun; 24(4):1237-42. PubMed ID: 20149858
[TBL] [Abstract][Full Text] [Related]
19. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
Park WH; Kim SH
Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitor MG132 reduces growth of As4.1 juxtaglomerular cells via caspase-independent apoptosis.
Han YH; Park WH
Arch Toxicol; 2010 Sep; 84(9):689-98. PubMed ID: 20449726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]